Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis

Abstract

Background Delays in diagnosis and treatment of pulmonary tuberculosis are a major set-back to global tuberculosis control. There is currently no global evidence on the average delays thus, the most important contributor to total delay is unknown. We aimed to estimate average delay measures and to investigate sources for heterogeneity among studies assessing delay measures. Methods Systematic review of studies reporting mean (± standard deviation) or median (interquartile range, IQR) of patient, doctor, diagnostic, treatment, health system and/or total delays in journal articles indexed in PubMed. We pooled mean delays using random-effects inverse variance meta-analysis, investigated for variations in pooled estimates in subgroup analyses and explored for sources of heterogeneity using pre-specified explanatory variables. Results The systematic review included 198 studies (831,724 patients) from 78 countries. The median number of patients per study was 243 (IQR; 160–458) patients. Overall, the pooled mean total delay was 87.6 (95% CI: 81.4–93.9) days. The most important and largest contributor to total delay was patient delay with a pooled mean delay of 81 (95% CI: 70–92) days followed by doctor’s delay and treatment delay with pooled mean delays of 29.5 (95% CI: 25.9–33.0) and 7.9 (95% CI: 6.9–8.9) days respectively. There was considerable heterogeneity in all pooled analyses (I 2 > 95%). In the meta-regression models of mean delays, studies excluding extra-pulmonary tuberculosis patients reported increased mean doctor’s delay by 45 days on average, non-use of chest x-ray and conducting studies in high income countries decreased mean treatment delay by 20 and 22 days on average, respectively. Conclusion Strategies to address patients’ delay could have important implications for the success of the global tuberculosis control programmes.

Ending tuberculosis by 2030—Pipe dream or reality?

“…Patients must recognize they are ill and seek timely care, and health services must respond efficiently. Unfortunately, symptomatic patients can take up to 3 months to present to the health sector, which can take a further 1 month to diagnose TB (Bello et al, 2019). Health service capacity varies substantially both between and within countries, and large numbers of symptomatic patients attending health facilities are not diagnosed with TB because they do not receive appropriate radiographic or microbiological investigations (Kweza et al, 2018).…”

Health system delay in the treatment of tuberculosis patients in Ethiopia: a systematic review and meta-analysis

“…days (24), India the pooled median health system delay was 31 days (22) and another systematic review done in 78 countries, the pooled health system delay was 39.3 days (56). This finding also lower than primary studies done Vietnam 42 days (26) , Taiwan 29 days (57) ,china 26 days (58) and Turkey 64.1 days (59).…”

Determination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey

“…In a review study in which studies from 78 countries were evaluated and systematically compiled, the patient delay was found as 81 days, the physician delay was 29.5 days, and the treatment delay was 7.9 days [5]. The diagnosis delay was still an obstacle in TB prevention and control programs in low-and medium-income levels [11].…”

“…Within the context of prevention, the End TB Strategy suggests a patient-centered care to focus on early diagnosis, treatment, and prevention [4]. Delays in the diagnosis and treatment of pulmonary TB are a great obstacle in the elimination of TB globally [5].…”